Roxadustat in Kidney Transplant Recipients with ESA-Hyporesponsive Anemia: A Prospective Single-Center Cohort Study. [PDF]
Franco A +6 more
europepmc +1 more source
Thrombotic outcomes and mortality with roxadustat for anemia in chronic kidney disease: a systematic review and meta-analysis of randomized trials. [PDF]
Tang J, Zheng Y, Pan L, Li X, Zhong Y.
europepmc +1 more source
Anemia correction using Roxadustat among MHD patients: 50mg versus 100mg dosing schedules. [PDF]
K S A, M MI, Ripa RA, K U M SN, Md BA.
europepmc +1 more source
Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies. [PDF]
Serrano B +5 more
europepmc +1 more source
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial. [PDF]
Wang H +25 more
europepmc +1 more source
An exploratory study of the pharmacokinetics, safety, and erythropoietic effects of roxadustat in healthy cats. [PDF]
Shitamori F +9 more
europepmc +1 more source
Roxadustat induced fetal hemoglobin in anemic CKD patients: a dual-center real-world observational cohort study. [PDF]
Gou W +15 more
europepmc +1 more source
Roxadustat for Erythropoiesis-Stimulating Agent Hyporesponsive Anemia in Hemodialysis: Multicenter Retrospective Analysis. [PDF]
Ozturk I +11 more
europepmc +1 more source

